GlassScriptPhysician profile
Erasto Canales
NPI 1396713616
$672.38
in general payments reported to CMS, 2019-2025
16 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.30 · 2020: $24.71 · 2021: $79.58 · 2022: $17.26 · 2023: $92.01 · 2024: $148 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $112.69 | 2021-2025 | Qulipta |
| Astellas Pharma US INC | $92.77 | 2023-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.23 | 2023-2025 | Xifaxan |
| Cumberland Pharmaceuticals, INC. | $66.23 | 2019-2024 | Kristalose |
| Gm Pharmaceuticals, INC. | $63.93 | 2025 | Vanacof |
| Dexcom, INC. | $39.67 | 2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $35.29 | 2023-2025 | Seglentis, Zoryve |
| Organon LLC | $34.29 | 2025 | Nexplanon |
| Baxter Healthcare | $32.82 | 2025 | Perclot |
| Davol INC. | $24.73 | 2024 | Arista Ah Flexitip |
| Inspire Medical Systems, INC. | $19.02 | 2025 | Inspire |
| Shield Therapeutics INC | $17.58 | 2024 | |
| Lilly USA, LLC | $17.45 | 2024 | Jardiance |
| Duchesnay USA Incorporated | $14.06 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.99 | 2023 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erasto Canales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.